期刊文献+

Survivin和VEGF在肾细胞癌中的表达及意义

The expression and clinical significance of Survivin and VEGF in renal cell carcinoma
下载PDF
导出
摘要 目的探讨Suvrivin、VEGF蛋白在肾细胞癌发生和进展中的作用。方法采用免疫组化SP法和蛋白印记法检测10例正常肾脏组织,32例肾癌组织中Survivni、VEGF蛋白的表达。结果 Survivin和VEGF在肾癌组织中的阳性表达率为53.1%和34.4,在正常肾组织中均不表达,其表达随肿瘤的临床分期、病理分级的增高而增强,两者表达水平间呈正相关关系(P=0.018)。RCC组织经Western-blot技术检测后均表现为包含有1条相对分子量约为16.5 kD及21 kD的特异性条带,而正常肾组织经Western-blot技术检测后呈低表达或不表达状态。结论肾癌组织中Survivin与VEGF的表达均上调,共同参与肾癌的发生和发展,联合检测肾癌组织Survivin和VEGF的表达对判定预后和指导治疗有一定意义。 Objective To investigate the expression of survivin,VEGF and their clinical significance in renal cell carcinoma(RCC).Methods The expression of Survivin and VEGF protein in the tissue of 32 cases of RCC and 10 cases of normal kidney was examined by Streptavidin-Peroxidase(SP) immunohistochemistry and Westeren blot.Results The positive expression rate of Survivin and VEGF in RCC tissue was respectively 53.1% and 34.4%,and there was no Survivin and VEGF protein expressed in the tissue of normal kidney.The expression of Suvrivin and VEGF were positively correlated in RCC(P = 0.018).Conclusion Survivin and VEGF are over-expressed in gastric cancer tissues.The progression of gastric cancer is related to the up-regulation of expression of survivin and VEGF and the expression of survivin and VEGF has a close correlation.Combination of VEGF and survivin detection is helpful to evaluate the capability of the tumor invasion,metastasis in gastric cancer.They are indexes to know the biological behavior of gastric cancer and serve as fairly good markers for prognosis and therapy.
出处 《宁夏医学杂志》 CAS 2013年第7期582-585,I0001,共5页 Ningxia Medical Journal
关键词 肾细胞癌 生存蛋白 血管内皮生长因子 免疫组化SP 蛋白印记 Renal cell carcinoma Survivin Vascular endothelial growth factor Streptavidin-peroxidase Immunohistochemistry renaxcexlcareinoma
  • 相关文献

参考文献10

  • 1Uzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist fas - mediated cell death[J]. Oncogene,2000,19(10) :1346 - 1353.
  • 2Ambrosini G, Adida C, Ahieri DC. A novel anti - apoptosis gene, survivin,expressed in cancer and lymphoma [ J]. Nat Med, 1997,3 (8) :917 -921.
  • 3Olie RA, Simoes -Wnst AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy [ J ]. Cancer Res ,2000, 60( 11 ) :2805 - 2809.
  • 4Fortugno P, Wall NR, Giodini A, et al. Survivin exists in immuno- chemically distinct subceUular pools and is involved in spindle microtubule function [ J ]. J Cell Sci,2002,115 ( 3 ) : 575 - 585.
  • 5Mckay TR, Bell S, Tenev T, et al. Procaspase 3 expression in ovari- an carcinoma cells increases survivin transcription which can be countered with a dominant - negative mutant, survivin T34A, a combination gene therapy strategy [ J ]. Oncogene, 2003,22 ( 23 ) : 3539 - 3547.
  • 6Cho GS, Ahn TS. Expression of the survivin -2B splice variant rela- tied to the progression of colorectal carcinoma [ J ]. J Korean Surg Soc ,2011,80 (6) :404 - 411.
  • 7李旭东,曾津,陈玉乐,薛玉泉,吴开杰,杨增雷,张岗,王新阳.Survivin在人肾透明细胞癌中的表达及其临床意义[J].现代泌尿外科杂志,2010,15(2):89-92. 被引量:2
  • 8Srinivasan R, Armstrong A J, Dahut W, et al. Anti - angiogenic ther- apy in renal cell cancer [ J ]. Bju Int, 2007,99 ( 5 ) : 1296.
  • 9Jacobson J, Rasmuson T, Grankvist K, et al. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma [ J ]. J Uro1,2000,163:343 - 347.
  • 10O'connor DS, Schechner JS, Adida C, et al. Control of apoptosis- during angiogenesis by survivin expression in endothelial cells [ J ]. Am J Patho1,2000,156 ( 2 ) : 393 - 398.

二级参考文献12

  • 1MURAl M, OYA M. Renal cell carcinoma: Etiology, incidence and epidemiology [J]. Curr Opin Urol, 2004, 14(4) : 229 - 233.
  • 2BRIEGER J, WEIDT EJ, SCHIRMACHER P, et al. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal ceil carcinomas is correlated with vascular growth: an in vivo study on 29 tumors [J]. J Mol Med, 1999, 77(6) :505-510.
  • 3AMBROSINI G, ADIDA C, ALTIERI DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J]. Nat Med, 1997, 3(8) : 917-921.
  • 4ELLEDGE RM. Assessing P53 status in breast cancer prognosis: Where should you put the thermometer if you think your P53 is sick [J]. J Natl Cancer Inst, 1996, 88 (3-4) :141-143.
  • 5OBIOL-PARDO C, GRANADINO-ROLDAN JM, RUBIO- MARTINEZ J. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins [J]. J Mol Recognit, 2008, 21(3) :190-204,.
  • 6MITA AC, MITA MM, NAWROCKI ST, et al. Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics [J]. Clin Cancer Res, 2008, 14(16) :5000-5005.
  • 7LU J, TAN M, HUANG WC, et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance [J]. Ctin Cancer Res,2009, 15(4) : 1326- 1334.
  • 8YAMAMOTO H, NGAN CY, MONDEN M. Cancer cells survive with survivin [J]. Cancer Sci,2008, 99(9):1709-1714.
  • 9ZAMPARESE R, PANNONE G, SANTOROA,et al. Survivin expression in renal cell carcinoma [J]. Cancer Invest,2008, 26 (9) :929-935.
  • 10WANG GC, HSIEH PS, HSU HH,et al. Expression of cortactin and survivin in renal celt carcinoma associated with tumor aggressiveness [J]. World J Urol,2009, 27(4) : 557-563.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部